Open | - |
Close | - |
Volume / Avg. | 11.070K / 607.703K |
Day Range | - - - |
52 Wk Range | 0.622 - 2.500 |
Market Cap | $21.497M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 8.87% |
Days to Cover | 3.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX), Kiora Pharmaceuticals (NASDAQ:KPRX) and CalciMedica (NASDAQ:CALC).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 6.00 expecting ITRM to rise to within 12 months (a possible 275.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.6 last updated Today at March 19, 2024 at 8:51 AM EDT.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.